Nikon Precision (Shanghai) Co., Ltd.

Five-year-old Leif Anderson experienced spontaneous retinal detachment. His father Douglas is dedicated to developing an advanced retinal imaging system.

A five-year-old boy was blinded after retinal detachment was not detected during routine eye examination. His father is committed to researching retinal imaging technology to help more ophthalmic care professionals.

Crombie Anderson Associates推出Plus 180项目。

欧堡原先注册名称为Zenoplan Ltd，后变更为Besca Ltd，然后成为Optos Ltd。

最初的设计草图带来技术突破，申请了首项专利。

Investors Mike Rutterford, Douglas Anderson, Barry Sealey provided help and support. The first Plus 180 was exhibited at the American Ophthalmological Society.

Initial concept operation and design of the first ultra-wide-angle retinal imaging device.

Panoramic 200 received a patent and was approved for sale in Europe. US headquarters opened.

Panoramic 200 launched at the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery.

第一个成像的婴儿Mirren Stevens。

尼康精机（上海）有限公司于2002年在上海成立。从半导体光刻机的售后服务业务开始，逐步扩展到FPD光刻机的售后服务及二手设备销售、应用服务等业务。为应对客户的各种需求，公司不断提升服务品质。

成立尼康精机（上海）有限公司（以下简称“NPC”）

开始半导体光刻机（8英寸）技术支持业务

Optos officially established sales strategy and fully entered the Chinese ophthalmology market.

成立尼康仪器（上海）有限公司（以下简称“NIS”）

成立北京事务所（2007年变更为北京分公司）

Establishment of Guangzhou Office (renamed Guangzhou Branch in 2007)

Optos在伦敦证券交易所上市，庆祝入场和无条件交易的第一天。

第1000万名患者接受欧堡检查。

成立大连分公司

开始销售X射线/CT CMM激光扫描设备

Optos nominated for the European Inventor of the Year award.

开始半导体光刻机（12英寸）技术支持业务

开始FPD光刻机技术支持业务

Health Care (hereinafter referred to as "HC") department established Nikon Biological Imaging (Exhibition) Center at Tsinghua University

Optos收购Opto Global。开始制造业精益之旅。

Establishment of Shanghai Industrial Equipment Exhibition Hall (Shanghai Caohejing Area)

HC部门　在复旦大学建立尼康生物影像中心

推出初代Daytona。第3000万名患者接受欧堡检查。Optos出于OCT技术收购Opko Instrumentation。荣获2011年最佳技术PLC奖第二名。

开始半导体浸润式光刻机技术支持业务

Joslin糖尿病研究结果表明，欧堡与ETDRS金标准相当。

开始二手半导体光刻机销售业务

第4000万名患者接受欧堡检查。Joslin的第二项研究表明，周边部病变为主的患者进展到更严重视网膜病变的风险增加4倍。

Optos荣获European Mediscience Awards奖年度技术奖。推出ProView™软件。

开始HC显微镜套机产地直销

FPD lithography machine sales in China surpass 100 units

新展厅开放（扩大）

尼康株式会社收购Optos。

Over 50 million retinal images captured worldwide with equipment installed reaching 10,000 units. Nikon and Verily established a strategic alliance to develop machine learning-supported solutions for diabetes-related eye diseases.

开始半导体光刻机翻新改造及性能提升等业务

Celebrating Nikon's 100th anniversary with HC Nikon Forum held in Zhangjiajie, China

Optos celebrated its 25th anniversary. OPERA study showed 97% of AMD patients have peripheral vitreous membrane warts.

开始半导体光刻机装机业务

停止销售CMM设备

开始运营HC微信公众号

DRCR方案AA研究出版物验证UWF等同于ETDRS。

Over 16,000 devices installed, imaging over 150 million patients, more than 1,000 clinical papers published, and ultra-wide-angle definition papers released.

HC部门开始Buy & Sell业务

Head office relocated to Shanghai Qiantan area

Participation in the 4th China International Import Expo (“CIIE”)

设立眼科部门，开始销售眼底相机

产业部门开始Buy & Sell/产地直销业务

Exhibition hall relocated to Shanghai Meilong area

HC入驻上海张江药谷公共服务平台，建立面向企业的生物影像中心

HC部门与青岛大学肿瘤研究院共同建立肿瘤微观成像创新中心

HC入驻北京亦庄医药园，建立面向企业的生物影像中心

尼康精机（上海）有限公司与尼康仪器（上海）有限公司合并

取得AEO高级认证

展厅迁移至上海张江